Romanian Society of Pharmaceutical Sciences
 

« Back to Farmacia Journal 2/2016

BISPHOSPHONATES – A GOOD CHOICE FOR WOMEN WITH TYPE 2 DIABETES AND POSTMENOPAUSAL OSTEOPOROSIS?

RALUCA NAN1, DANIEL GRIGORIE2,3*, ADRIAN CURSARU4, ALINA ȘUCALIUC2,3,
RAMONA DRĂGUȚ1, EMILIA RUSU1, MĂDĂLINA MUȘAT2,3, GABRIELA RADULIAN1,5

1.Department of Diabetes 2, ”Prof. Dr. N. Paulescu” National Institute of Diabetes, Nutrition and Metabolic Diseases, 5-7 Ion Movilă Street, Bucharest, Romania
2 .”C. I. Parhon” National Institute of Endocrinology, 34-36 Aviatorilor Boulevard, Bucharest, Romania
3 .Department of Endocrinology, “Carol Davila” University of Medicine and Pharmacy, 34-36 Aviatorilor Boulevard, Bucharest, Romania
4 .Department of Orthopaedics and Traumatology, “Carol Davila” University of Medicine and Pharmacy, 169 Splaiul Independenței, Bucharest, Romania
5 .Department of Hygiene and Diabetes, “Carol Davila” University of Medicine and Pharmacy, 17-23 Calea Plevnei, Bucharest, Romania

Download Full Article PDF

The aim of the study was to assess the levels of biochemical markers of bone turnover (BTMs) and the effects of bisphosphonates therapy (BT) on BTMs and bone mineral density (BMD) in women with type 2 diabetes (T2D) and recently diagnosed postmenopausal osteoporosis. Two groups of women have been evaluated at baseline and one year later: a group of 35 women diagnosed with T2D and newly postmenopausal osteoporosis (diabetic group) and a group of 35 women only with postmenopausal osteoporosis (control group). Consistent with other studies, we found that bone turnover was reduced in T2D patients, as both serum osteocalcin and C-terminal crosslink of collagen (CTX) were significantly lower than controls. After a year of BT, both osteocalcin and CTX did not change in the diabetic group and decreased in the control group. Significant increases in BMD, especially at the lumbar spine, were noted in both groups. In diabetic women, bone turnover is low and does not change after one year of BT, but there is a significant benefit at lumbar spine BMD.